GDC Property Terminology

Preferred Label : GDC Property Terminology;

NCIt synonyms : Genomics Data Commons Property Terminology;

NCIt definition : Terminology that supports the properties found in the Genomic Data Commons (GDC) data model.;

NCI Metathesaurus CUI : CL1643233;

Détails

Origin ID

C177536;

UMLS CUI

C5447839;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
subset_includes_concept
- 28S Ribosomal RNA to 18S Ribosomal RNA Ratio [NCIt concept]
- A260 to A280 Ratio [NCIt concept]
- AIDS-Related Risk Factor [NCIt concept]
- AJCC Cancer Staging Manual [NCIt concept]
- AJCC v8 Clinical M Category [NCIt concept]
- AJCC v8 Clinical N Category [NCIt concept]
- AJCC v8 Clinical Stage [NCIt concept]
- AJCC v8 Clinical T Category [NCIt concept]
- AJCC v8 Pathologic M Category [NCIt concept]
- AJCC v8 Pathologic N Category [NCIt concept]
- AJCC v8 Pathologic Stage [NCIt concept]
- AJCC v8 Pathologic T Category [NCIt concept]
- ASCII Encoding Version for Read Group QC [NCIt concept]
- Additional Pathologic Findings Question [NCIt concept]
- Administered Treatment Clinical Trial Indicator [NCIt concept]
- Adrenal Hormone Indicator [NCIt concept]
- Adverse Event [NCIt concept]
- Adverse Event Grade Code [NCIt concept]
- Adverse Event Treatment Emergent Indicator [NCIt concept]
- Age Data Obfuscated Indicator [NCIt concept]
- Age Started [NCIt concept]
- Age at Last Exposure [NCIt concept]
- Age in Days at Diagnosis [NCIt concept]
- Age in Years at Index Date [NCIt concept]
- Age in Years of Patient Relative at Cancer Diagnosis [NCIt concept]
- Age-Days [NCIt concept]
- Agent Unit of Measure [NCIt concept]
- Alcohol Use History [NCIt concept]
- Alcoholic Beverage [NCIt concept]
- Analyte Type [NCIt concept]
- Anaplasia Descriptor [NCIt concept]
- Anaplasia Indicator [NCIt concept]
- Anatomic Site for Involved Surgical Margin [NCIt concept]
- Anatomic Site of Maximum Tumor Bulk [NCIt concept]
- Anatomic Site or Organ with Contiguous Invasion [NCIt concept]
- Aneuploidy [NCIt concept]
- Ann Arbor B Symptoms Indicator [NCIt concept]
- Ann Arbor Clinical Stage [NCIt concept]
- Ann Arbor Extranodal Involvement Indicator [NCIt concept]
- Ann Arbor Pathologic Stage [NCIt concept]
- Antigen [NCIt concept]
- Asbestos Exposure Mineral Type Indicator [NCIt concept]
- Assay Color Channel Name [NCIt concept]
- Assay Plate Identifier [NCIt concept]
- Assay Plate Well Identifier [NCIt concept]
- Average Number Cigarettes Smoked a Day Question [NCIt concept]
- Average Number of Alcoholic Drinks per Day Question [NCIt concept]
- Average Number of Days per Week One Drinks Alcohol Question [NCIt concept]
- Average Number of Exercise Days per Week Question [NCIt concept]
- Average Read Length [NCIt concept]
- Average Sequence Insert Size [NCIt concept]
- B-Symptoms [NCIt concept]
- Base Mismatch Proportion Data [NCIt concept]
- Best Overall Response [NCIt concept]
- Biospecimen Collection Chronology [NCIt concept]
- Biospecimen Collection Method [NCIt concept]
- Biospecimen Core Resource Identifier [NCIt concept]
- Biospecimen Growth Rate [NCIt concept]
- Biospecimen Laterality [NCIt concept]
- Biospecimen Portion Creation Date Time [NCIt concept]
- Biospecimen Portion Number [NCIt concept]
- Biospecimen Sequence Number [NCIt concept]
- Biospecimen Type [NCIt concept]
- Biospecimen Volume [NCIt concept]
- Birth Country [NCIt concept]
- Birth Year [NCIt concept]
- Blood Test Range Lower Limit of Normal [NCIt concept]
- Blood Test Range Upper Limit of Normal [NCIt concept]
- Body Height [NCIt concept]
- Body Mass Index [NCIt concept]
- Body Surface Area [NCIt concept]
- Bone Marrow Malignant Cell Indicator [NCIt concept]
- Breslow Thickness [NCIt concept]
- Burkitt Lymphoma Clinical Variant Indicator [NCIt concept]
- CD4 Expressing Cell Count [NCIt concept]
- CD4 Expressing Cell Nadir [NCIt concept]
- Cancer Cellularity Measurement [NCIt concept]
- Cancer DNA to Total Tumor Tissue DNA Ratio Measurement [NCIt concept]
- Cancer Detection Method [NCIt concept]
- Cancer Model Distributor Reference Identifier [NCIt concept]
- Cause of Death [NCIt concept]
- Cell Count [NCIt concept]
- ChIP-Seq Antibody Name [NCIt concept]
- ChIP-Seq Target Name [NCIt concept]
- Chemical Exposure Type Indicator [NCIt concept]
- Chemotherapeutic Cycle Number [NCIt concept]
- Child-Pugh Clinical Classification [NCIt concept]
- Children's Oncology Group Liver Tumor Staging System [NCIt concept]
- Children's Oncology Group Neuroblastoma Risk Group Staging System [NCIt concept]
- Children's Oncology Group Renal Cancer Staging System [NCIt concept]
- Children's Oncology Group Retinoblastoma Risk Group Staging System [NCIt concept]
- Chromosomal Translocation [NCIt concept]
- Chromosome [NCIt concept]
- Chromosome Arm [NCIt concept]
- Chromosome Band [NCIt concept]
- Circumferential Resection Margin [NCIt concept]
- Clark Level Finding [NCIt concept]
- Clinical Center Type Acronym [NCIt concept]
- Clinical Distant Metastasis ENSAT Staging Finding v7 [NCIt concept]
- Clinical Finding Detected by Imaging [NCIt concept]
- Clinical Intervention or Procedure [NCIt concept]
- Clonality [NCIt concept]
- Columnar Mucosa Indicator [NCIt concept]
- Comorbid Condition [NCIt concept]
- Comorbidity [NCIt concept]
- Comorbidity Diagnostic Method [NCIt concept]
- Concentration [NCIt concept]
- Concurrent Chemoradiation [NCIt concept]
- Condition or Disease under Study [NCIt concept]
- Consistent Pathology Review Indicator [NCIt concept]
- Corrected Undescended Testis Laterality [NCIt concept]
- Country of Residence at Enrollment [NCIt concept]
- Cross-Contaminated Read Fraction [NCIt concept]
- Curated Model Identifier [NCIt concept]
- Current Biospecimen Weight [NCIt concept]
- Current Smoking Frequency Question [NCIt concept]
- Cytogenetic Risk Group-CALGB Criteria for AML [NCIt concept]
- DLCO % REF [NCIt concept]
- Data Analysis Workflow Name [NCIt concept]
- Data Analysis Workflow URL [NCIt concept]
- Data Analysis Workflow Version [NCIt concept]
- Deceased Family Member [NCIt concept]
- Depth of Tumor Invasion [NCIt concept]
- Diabetes Therapy [NCIt concept]
- Diagnosis Pathologically Confirmed Indicator [NCIt concept]
- Diagnostic Method [NCIt concept]
- Disease Grade Qualifier [NCIt concept]
- Disease Involvement Site [NCIt concept]
- Disease Progression Evidence [NCIt concept]
- Disease Recurrence Evidence [NCIt concept]
- Disease Response [NCIt concept]
- Disease or Disorder [NCIt concept]
- Distance of Closest Surgical Margin [NCIt concept]
- Document Version Identifier [NCIt concept]
- Dose [NCIt concept]
- Dose Frequency [NCIt concept]
- Double-Expressor Lymphoma [NCIt concept]
- Drinking Status [NCIt concept]
- Dysplasia [NCIt concept]
- Dysplasia Degree Question [NCIt concept]
- ECOG Performance Status [NCIt concept]
- Education Level [NCIt concept]
- Elapsed Time Between Clamping and Freezing [NCIt concept]
- Elapsed Time Between Excision and Freezing [NCIt concept]
- Electronic File Content Type [NCIt concept]
- Electronic File Format [NCIt concept]
- Embolic Agent [NCIt concept]
- Enneking Metastasis [NCIt concept]
- Enneking Staging System [NCIt concept]
- Enneking Surgical Grade [NCIt concept]
- Enneking Tumor Type [NCIt concept]
- Epithelioid Cell Percent Range [NCIt concept]
- Esophageal Columnar Dysplasia Degree Question [NCIt concept]
- Esophageal Columnar Metaplasia Indicator [NCIt concept]
- Esophageal Columnar Mucosa Goblet Cell Indicator [NCIt concept]
- Estimated Read Error due to Contamination [NCIt concept]
- Ethnic Group [NCIt concept]
- European LeukemiaNet Risk Classification [NCIt concept]
- Exon of Interest Number [NCIt concept]
- Experiment Name [NCIt concept]
- Experimental Method [NCIt concept]
- Exposure Duration [NCIt concept]
- Exposure Duration Years [NCIt concept]
- Exposure Duration in Hours per Day [NCIt concept]
- Exposure Source Indicator [NCIt concept]
- Extracapsular Extension Present Indicator [NCIt concept]
- Extracapsular Extent Indicator [NCIt concept]
- Extraocular Nodule Size [NCIt concept]
- Extrascleral Extension Present Indicator [NCIt concept]
- Extrathyroid Extent Indicator [NCIt concept]
- Eye Color [NCIt concept]
- FASTQ File Name [NCIt concept]
- FEV1% REF Post-Bronchodilator [NCIt concept]
- FEV1% REF Pre-Bronchodilator [NCIt concept]
- FEV1/FVC Post-Bronchodilator [NCIt concept]
- FEV1/FVC Pre-Bronchodilator [NCIt concept]
- FFPE Indicator [NCIt concept]
- FIGO Stage [NCIt concept]
- FIGO Staging Edition Year [NCIt concept]
- Family Cancer History [NCIt concept]
- Family Cancer History Relative Primary Diagnosis Question [NCIt concept]
- Family Cancer History Relative Sex Question [NCIt concept]
- Family History of Smoking [NCIt concept]
- First Post-treatment Event [NCIt concept]
- First Variant Gene Symbol [NCIt concept]
- Freezing Method Name [NCIt concept]
- French-American-British Classification [NCIt concept]
- Fusion Gene Downstream Gene Symbol [NCIt concept]
- Gastroesophageal Junction Involvement Indicator [NCIt concept]
- Gender [NCIt concept]
- Gene Product Variation Site [NCIt concept]
- Genetic Variant Origin Indicator [NCIt concept]
- Genome Doubling Event Number [NCIt concept]
- Genome-Wide DNA Copy Number [NCIt concept]
- Genomic Identifier [NCIt concept]
- Genotype Match Indicator for Normal/Tumor Matched Tissue Samples [NCIt concept]
- Gestational Age at Birth [NCIt concept]
- Gleason Score for Prostate Cancer [NCIt concept]
- Greatest Dimension Tumor [NCIt concept]
- Gross Tumor Weight [NCIt concept]
- HCMI Catalog Reference Number [NCIt concept]
- HIV Viral Load Measurement [NCIt concept]
- Hepatitis Serology [NCIt concept]
- Hepatitis Sustained Virologic Response [NCIt concept]
- High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements [NCIt concept]
- Highly Active Antiretroviral Therapy [NCIt concept]
- Histological Progression Indicator [NCIt concept]
- Histological Progression Type [NCIt concept]
- Histology ICD-O Morphology Code [NCIt concept]
- Histone [NCIt concept]
- Histone Variant [NCIt concept]
- Home Oxygen Therapy Use Duration Indicator [NCIt concept]
- Hormonal Contraception [NCIt concept]
- Hormone Replacement Therapy [NCIt concept]
- Hormone Replacement Therapy Status Indicator [NCIt concept]
- How Often Have Alcoholic Drink Question [NCIt concept]
- Hysterectomy [NCIt concept]
- Hysterectomy Margins Involved Indicator [NCIt concept]
- ICD-10 Code [NCIt concept]
- ICD-O-3 Morphology Term Diagnosis Question [NCIt concept]
- IRS Clinical Grouping System [NCIt concept]
- IRS Clinical Staging System [NCIt concept]
- Identifier [NCIt concept]
- Image Acquisition Date [NCIt concept]
- Image Anatomic Location [NCIt concept]
- Imaging Finding [NCIt concept]
- Imaging Magnification [NCIt concept]
- Imaging Procedure [NCIt concept]
- Immunosuppressant [NCIt concept]
- Index Date [NCIt concept]
- Individual Cancer History [NCIt concept]
- Information Source for Cause of Death [NCIt concept]
- Initial Biospecimen Weight [NCIt concept]
- Initial Neoplastic Disease Extent Indicator [NCIt concept]
- Instrument Model [NCIt concept]
- Intent To Treat [NCIt concept]
- International Classification of Diseases, Tenth Revision [NCIt concept]
- International Germ Cell Consensus Risk Classification [NCIt concept]
- International Neuroblastoma Pathology Classification [NCIt concept]
- International Neuroblastoma Pathology Classification Histologic Group [NCIt concept]
- International Neuroblastoma Risk Group Staging System [NCIt concept]
- International Neuroblastoma Staging System [NCIt concept]
- International Prognostic Index [NCIt concept]
- International Society of Urological Pathology Gleason Grade Group [NCIt concept]
- International Staging System Stage [NCIt concept]
- Intratubular Germ Cell Neoplasia Present Indicator [NCIt concept]
- Intron of Interest Number [NCIt concept]
- Is Extranodal Tumor Involvement Present Question [NCIt concept]
- Is Individual Lost to Follow-Up Question [NCIt concept]
- Is Lymphatic Invasion Present Question [NCIt concept]
- Is Macroscopic Satellite Nodule Present Question [NCIt concept]
- Ishak Score [NCIt concept]
- Karnofsky Performance Status [NCIt concept]
- Laboratory Procedure [NCIt concept]
- Laboratory Specimen Type [NCIt concept]
- Laboratory Test Result [NCIt concept]
- Largest Diameter of Extrapelvic Peritoneal Metastasis [NCIt concept]
- Last Known Neoplastic Disease Extent Indicator [NCIt concept]
- Laterality [NCIt concept]
- Legacy Project Archive Indicator [NCIt concept]
- Library Sequencing [NCIt concept]
- Library Strand Sequenced Question [NCIt concept]
- Localized Neoplasm [NCIt concept]
- Longest Diameter [NCIt concept]
- Longest Duration of First Symptom Related to Diagnosis [NCIt concept]
- Lymph Node Dissection Site [NCIt concept]
- Lymph Node Dissection Type [NCIt concept]
- Lymph Node Involvement [NCIt concept]
- Lymph Node by Anatomic Site [NCIt concept]
- Marital Status [NCIt concept]
- Masaoka-Koga Stage [NCIt concept]
- Maximum Dose Amount [NCIt concept]
- Medication Course Number [NCIt concept]
- Medulloblastoma Molecular Subtypes [NCIt concept]
- Melanoma with Known Primary Indicator [NCIt concept]
- Menopause Status [NCIt concept]
- Metaplasia Indicator [NCIt concept]
- Metastatic Diagnosis [NCIt concept]
- Microassay Chip Identifier [NCIt concept]
- Microassay Chip Position Identifier [NCIt concept]
- Micrometastasis Present Indicator [NCIt concept]
- Microsatellite Instability Overall Status [NCIt concept]
- Minimal Submucosal Invasion [NCIt concept]
- Minimum Diameter [NCIt concept]
- Mismatch Repair Gene Mutation [NCIt concept]
- Mitosis-Karyorrhexis Index [NCIt concept]
- Mitotic Count [NCIt concept]
- Molecular Analysis [NCIt concept]
- Molecular Sequence Variation [NCIt concept]
- Molecular Sequence Variation Type [NCIt concept]
- Molecular Test Analyte Type [NCIt concept]
- Morphologic Architectural Pattern [NCIt concept]
- Multiplex Sequencing Sample Barcode [NCIt concept]
- Myasthenia Gravis Foundation of America Class [NCIt concept]
- NCBI Transcript Identifier [NCIt concept]
- Necrosis Indicator [NCIt concept]
- No Matched Normal Low Pass Whole Genome Sequencing Indicator [NCIt concept]
- No Matched Normal Targeted Sequencing Indicator [NCIt concept]
- No Matched Normal Whole Exome Sequencing Indicator [NCIt concept]
- No Matched Normal Whole Genome Sequencing Indicator [NCIt concept]
- Non-Oncologic Therapeutic Agent [NCIt concept]
- Non-nodal Regional Disease Indicator [NCIt concept]
- Non-nodal Tumor Deposits Indicator [NCIt concept]
- Normal and Tumor Sample Distance [NCIt concept]
- Normal or Tumor Sample Pathology Indicator [NCIt concept]
- Nucleic Acid Aliquot Volume [NCIt concept]
- Nucleic Acid Extraction Method [NCIt concept]
- Nucleotide Base Caller Name [NCIt concept]
- Nucleotide Base Caller Version [NCIt concept]
- Nucleotide Sequencing Aliquot Weight [NCIt concept]
- Nucleotide Sequencing Analyte Volume [NCIt concept]
- Nucleotide Sequencing Analyte Weight [NCIt concept]
- Nucleotide Sequencing Date [NCIt concept]
- Nucleotide Sequencing Site Name [NCIt concept]
- Number of Days Between Index Date and Adverse Event [NCIt concept]
- Number of Days Between Index Date and Best Overall Response [NCIt concept]
- Number of Days Between Index Date and Comorbidity [NCIt concept]
- Number of Days Between Index Date and Death [NCIt concept]
- Number of Days Between Index Date and Diagnosis [NCIt concept]
- Number of Days Between Index Date and Disease Progression [NCIt concept]
- Number of Days Between Index Date and Disease Recurrence [NCIt concept]
- Number of Days Between Index Date and First Event [NCIt concept]
- Number of Days Between Index Date and Imaging Procedure [NCIt concept]
- Number of Days Between Index Date and Laboratory Test [NCIt concept]
- Number of Days Between Index Date and Last Follow Up [NCIt concept]
- Number of Days Between Index Date and Last Known Disease Status [NCIt concept]
- Number of Days Between Index Date and Lost to Follow Up [NCIt concept]
- Number of Days Between Index Date and Nucleotide Sequencing Assay [NCIt concept]
- Number of Days Between Index Date and Participation Consent [NCIt concept]
- Number of Days Between Index Date and Pathology Review [NCIt concept]
- Number of Days Between Index Date and Progression Free Status [NCIt concept]
- Number of Days Between Index Date and Risk Factor Diagnosis [NCIt concept]
- Number of Days Between Index Date and Specimen Collection [NCIt concept]
- Number of Days Between Index Date and Treatment End [NCIt concept]
- Number of Days Between Index Date and Treatment Start [NCIt concept]
- Number of Discontiguous Lesions (New Tumor Event) [NCIt concept]
- Number of Disease-Involved Anatomic Sites [NCIt concept]
- Number of Elapsed Days Between Treatment and Outcome [NCIt concept]
- Number of Lymph Nodes Examined [NCIt concept]
- Number of Lymph Nodes Positive [NCIt concept]
- Number of Patient Relatives with History of Cancer [NCIt concept]
- Number of Peripancreatic Lymph Nodes Examined [NCIt concept]
- Number of Peripancreatic Lymph Nodes Positive [NCIt concept]
- Number of Pregnancies [NCIt concept]
- Number of Prostatic Chips Examined [NCIt concept]
- Number of Prostatic Chips Positive [NCIt concept]
- Number of RECIST Baseline Target Lesion [NCIt concept]
- Number of Recovered Cells Expected [NCIt concept]
- Number of Sequence Variants [NCIt concept]
- Number of Treated Lesions [NCIt concept]
- Number of Values in Staining Intensity Scale [NCIt concept]
- Number of Years in Occupation [NCIt concept]
- Occupation [NCIt concept]
- Other Molecular Analysis [NCIt concept]
- Outcome of Therapy [NCIt concept]
- Ovarian Capsule Status [NCIt concept]
- Ovarian Surface Involvement Indicator [NCIt concept]
- Pack Year [NCIt concept]
- Paired End Reads Indicator [NCIt concept]
- Papillary Renal Cell Carcinoma Type Indicator [NCIt concept]
- Parent with Radiation Exposure Indicator [NCIt concept]
- Passage Number [NCIt concept]
- Passive Smoke Exposure [NCIt concept]
- Pathogenicity [NCIt concept]
- Pathologic ENSAT Staging Finding v7 [NCIt concept]
- Pathologic Lymph Nodes ENSAT Staging Finding v7 [NCIt concept]
- Pathologic Primary Tumor ENSAT Staging Finding v7 [NCIt concept]
- Pathology Report UUID [NCIt concept]
- Percent Follicular Component [NCIt concept]
- Percent G/C [NCIt concept]
- Percent Gleason Patterns 4 and 5 [NCIt concept]
- Percent Inflammatory Marker Positive [NCIt concept]
- Percent Prostatic Involvement [NCIt concept]
- Percent Rhabdoid Features [NCIt concept]
- Percent Sarcomatoid Features [NCIt concept]
- Percent Tumor Cell Nuclei [NCIt concept]
- Percent Tumor Invasion [NCIt concept]
- Percent of Eosinophils [NCIt concept]
- Percent of Granulocytes [NCIt concept]
- Percent of Lymphocytes [NCIt concept]
- Percent of Monocytes [NCIt concept]
- Percent of Morphologically Normal Cells [NCIt concept]
- Percent of Necrosis [NCIt concept]
- Percent of Neutrophils [NCIt concept]
- Percent of Nucleotide Markers Exhibiting Instability [NCIt concept]
- Percent of Stromal Cells [NCIt concept]
- Percent of Tumor Cells [NCIt concept]
- Performed Procedure [NCIt concept]
- Perineural Invasion Assessment [NCIt concept]
- Peritoneal Cytology [NCIt concept]
- Peritoneal Wash Cytology Results Indicator [NCIt concept]
- Personal History Neoplasm Type Question [NCIt concept]
- Pharmacologic Substance [NCIt concept]
- Ploidy [NCIt concept]
- Population Group [NCIt concept]
- Predicted Maximum Read Length of Sequenced Fragment [NCIt concept]
- Predicted Mean Read Length of Sequenced Fragment [NCIt concept]
- Predicted Minimum Read Length of Sequenced Fragment [NCIt concept]
- Pregnancy Outcome [NCIt concept]
- Pregnant at Diagnosis Indicator [NCIt concept]
- Premature Birth Indicator [NCIt concept]
- Prepared Amount [NCIt concept]
- Prescribed Dose [NCIt concept]
- Prescribed Dose Units [NCIt concept]
- Preservation Procedure [NCIt concept]
- Pretreatment [NCIt concept]
- Primary Disease Diagnosis Submitter Identifier [NCIt concept]
- Primary Gleason Pattern [NCIt concept]
- Primary Site of Disease [NCIt concept]
- Prior Therapy [NCIt concept]
- Progression or Recurrence Type [NCIt concept]
- Progressive or Recurrent Disease Anatomic Site [NCIt concept]
- Progressive or Recurrent Disease Indicator [NCIt concept]
- Project Data Submission Enabled Indicator [NCIt concept]
- Project Name [NCIt concept]
- Project Release Request Indicator [NCIt concept]
- Project Reviewed by AWG Indicator [NCIt concept]
- Project Submission Status [NCIt concept]
- Proliferating Cell Count [NCIt concept]
- Proportion Covered at Read Depth of 10X [NCIt concept]
- Proportion Covered at Read Depth of 30X [NCIt concept]
- Proportion Targets with No Coverage [NCIt concept]
- Proportion of Duplicated Reads Data [NCIt concept]
- Proportion of Mapped Reads Data [NCIt concept]
- Prostate Level Disease Origin Indicator [NCIt concept]
- Prostate Zone of Disease Origin [NCIt concept]
- Protocol Identifier [NCIt concept]
- Protocol Treatment Arm [NCIt concept]
- RECIST Baseline Target Lesion Sum [NCIt concept]
- RNA Integrity Number [NCIt concept]
- Race [NCIt concept]
- Radiosensitizing Agent Used Indicator [NCIt concept]
- Read Depth [NCIt concept]
- Read Group Adapter Content Quality Control Indicator [NCIt concept]
- Read Group Basic Statistics Quality Control Indicator [NCIt concept]
- Read Group Kmer Content Quality Control Indicator [NCIt concept]
- Read Group Name [NCIt concept]
- Read Group Overrepresented Sequences Quality Control Indicator [NCIt concept]
- Read Group Pairs on Different Chromosomes Data [NCIt concept]
- Read Group Per Base N Content Quality Control Indicator [NCIt concept]
- Read Group Per Base Sequence Content Quality Control Indicator [NCIt concept]
- Read Group Per Base Sequence Quality Indicator [NCIt concept]
- Read Group Per Sequence G/C Content Quality Control Indicator [NCIt concept]
- Read Group Per Sequence Quality Score Indicator [NCIt concept]
- Read Group Per Tile Sequence Quality Indicator [NCIt concept]
- Read Group Sequence Duplication Levels Quality Control Indicator [NCIt concept]
- Read Group Sequence Length Distribution Quality Control Indicator [NCIt concept]
- Read Length [NCIt concept]
- Read Pair Number [NCIt concept]
- Reason Off Treatment [NCIt concept]
- Reason Treatment Not Administered [NCIt concept]
- Reflux Treatment Type Indicator [NCIt concept]
- Relationship Type [NCIt concept]
- Reported Average Base Quality [NCIt concept]
- Request for Submission Indicator [NCIt concept]
- Residual Disease [NCIt concept]
- Residual Tumor Size Measurement [NCIt concept]
- Restriction Endonuclease [NCIt concept]
- Rhabdoid Indicator [NCIt concept]
- Risk Factor [NCIt concept]
- Risk Factor Diagnostic Method [NCIt concept]
- Risk Factor Treatment Indicator [NCIt concept]
- Risk Factors for HIV Infection [NCIt concept]
- Route of Administration [NCIt concept]
- Sarcomatoid Features [NCIt concept]
- Scientific Data Type [NCIt concept]
- Second Exon of Interest Number [NCIt concept]
- Secondary Gleason Pattern [NCIt concept]
- Secondhand Smoke Exposure as a Child Question [NCIt concept]
- Select Exposure Types [NCIt concept]
- Selected Normal Low Pass Whole Genome Sequencing Indicator [NCIt concept]
- Selected Normal Targeted Sequencing Sample Aliquot Indicator [NCIt concept]
- Selected Normal Whole Exome Sequencing Indicator [NCIt concept]
- Selected Normal Whole Genome Sequencing Indicator [NCIt concept]
- Sequence Read Count [NCIt concept]
- Sequencing Adapter Name [NCIt concept]
- Sequencing Adapter Nucleic Acid Sequence [NCIt concept]
- Sequencing Flow Cell Barcode [NCIt concept]
- Sequencing Lane Identifier [NCIt concept]
- Sequencing Library Name [NCIt concept]
- Sequencing Library Preparation Kit Catalog Number [NCIt concept]
- Sequencing Library Preparation Kit Name [NCIt concept]
- Sequencing Library Preparation Kit Vendor Name [NCIt concept]
- Sequencing Library Preparation Kit Version [NCIt concept]
- Sequencing Size Selection Range [NCIt concept]
- Short Site Name [NCIt concept]
- Single Cell Library Construction Kit Identifier [NCIt concept]
- Site of Resection or Biopsy [NCIt concept]
- Slide Section Anatomic Site [NCIt concept]
- Smoke Exposure [NCIt concept]
- Smoking Cessation Year [NCIt concept]
- Smoking Onset Year [NCIt concept]
- Smoking Status [NCIt concept]
- Source Site Name [NCIt concept]
- Specify HPV Genotype [NCIt concept]
- Specimen Anatomic Site [NCIt concept]
- Spectrophotometry [NCIt concept]
- Spike-In Concentration [NCIt concept]
- Spike-In FASTA File Name [NCIt concept]
- Spike-In Inclusion Indicator [NCIt concept]
- Spindle Cell Percent Range [NCIt concept]
- Staining Intensity [NCIt concept]
- Staining Method [NCIt concept]
- Standard Deviation for Read Length of Sequenced Fragments [NCIt concept]
- Standardized Uptake Value [NCIt concept]
- Standardized Uptake Value Maximum [NCIt concept]
- Subclonal Genome to Total Tumor Tissue Genome Ratio Measurement [NCIt concept]
- Subject Consent Type [NCIt concept]
- Submitter Reviewing Project Indicator [NCIt concept]
- Submucosal Invasion Depth [NCIt concept]
- Substance Use Per Day Question [NCIt concept]
- Supratentorial Tumor Site [NCIt concept]
- Surgical Margins Status [NCIt concept]
- Suspected Reason for Disease Response [NCIt concept]
- TCGA BCR Tumor Code Identifier [NCIt concept]
- TCGA BCR Tumor Code Name [NCIt concept]
- Target Capture Kit Identifier [NCIt concept]
- Targeted Anatomic Site [NCIt concept]
- Technology Platform Version [NCIt concept]
- Tertiary Gleason Pattern [NCIt concept]
- Test Result Report [NCIt concept]
- Test Site Domain Name [NCIt concept]
- Test Value Percent Range [NCIt concept]
- Testicular Cancer Serum Markers Test Result [NCIt concept]
- Therapeutic Agent Category [NCIt concept]
- Therapeutic Agent Level Achieved Indicator [NCIt concept]
- Therapeutic Agent Targeted Administration Concentration [NCIt concept]
- Therapeutic Effect [NCIt concept]
- Therapeutic Effect Indicator [NCIt concept]
- Therapeutic Oxygen Use Indicator [NCIt concept]
- Therapeutic Procedure [NCIt concept]
- Time Between Waking and First Smoke Question [NCIt concept]
- Timepoint Event Category [NCIt concept]
- Tissue Microassay Array Position Identifier [NCIt concept]
- Tissue Sample [NCIt concept]
- Tissue or Organ of Origin [NCIt concept]
- Tobacco Type Used Question [NCIt concept]
- Total Area of Mitotic Index Ratio Analysis [NCIt concept]
- Total Number of Genetic Loci Assayed [NCIt concept]
- Total Number of Nucleotide Sequences Processed [NCIt concept]
- Total Number of Radiotherapy Dose Fractions Received [NCIt concept]
- Total Years Have Smoked Cigarettes Question [NCIt concept]
- Tracer [NCIt concept]
- Transglottic Extension of Laryngeal Tumor [NCIt concept]
- Treatment Duration in Days [NCIt concept]
- Treatment Regimen [NCIt concept]
- Trim Adapter Sequence Indicator [NCIt concept]
- Tumor Basal Diameter [NCIt concept]
- Tumor Burden [NCIt concept]
- Tumor Classification [NCIt concept]
- Tumor Depth Descriptor [NCIt concept]
- Tumor Focality [NCIt concept]
- Tumor Grade Evaluation Tier Number [NCIt concept]
- Tumor Infiltrating Lymphocytes Finding Indicator [NCIt concept]
- Tumor Infiltrating Macrophages Finding Indicator [NCIt concept]
- Tumor Length [NCIt concept]
- Tumor Measurement Method [NCIt concept]
- Tumor Ploidy [NCIt concept]
- Tumor Regression Grade [NCIt concept]
- Tumor Shape Observed Descriptor [NCIt concept]
- Tumor Thickness [NCIt concept]
- Tumor Width [NCIt concept]
- Type [NCIt concept]
- UICC Clinical M Category [NCIt concept]
- UICC Clinical N Category [NCIt concept]
- UICC Clinical Stage [NCIt concept]
- UICC Clinical T Category [NCIt concept]
- UICC Pathologic M Category [NCIt concept]
- UICC Pathologic N Category [NCIt concept]
- UICC Pathologic Stage [NCIt concept]
- UICC Pathologic T Category [NCIt concept]
- UICC Staging System Manual [NCIt concept]
- Ulcer Indicator [NCIt concept]
- Undescended Testis Corrected Age Range [NCIt concept]
- Undescended Testis Corrected Indicator [NCIt concept]
- Undescended Testis Corrected Method [NCIt concept]
- Undescended Testis History Indicator [NCIt concept]
- Undescended Testis Laterality [NCIt concept]
- Unit for Functional Test Results [NCIt concept]
- Unit of Length [NCIt concept]
- Variant Codon Position Number [NCIt concept]
- Vascular Invasion Assessment [NCIt concept]
- Vascular Invasion Descriptor [NCIt concept]
- Vital Status [NCIt concept]
- WEISS Criteria [NCIt concept]
- WEISS System [NCIt concept]
- WHO Central Nervous System Grade [NCIt concept]
- WHO Neuroendocrine Tumor Grade [NCIt concept]
- Was Lymph Node Dissection Performed Question [NCIt concept]
- What is the First Presenting Symptom Related to Disease Question [NCIt concept]
- What is the Hormonal Contraceptive Use Status Question [NCIt concept]
- Whole Genome Sequencing Read Depth [NCIt concept]
- Wilms Tumor Histologic Subtype [NCIt concept]
- Year of Death [NCIt concept]
- Year of Initial Cancer Diagnosis [NCIt concept]
- Year of Last Follow Up [NCIt concept]
- Year of Pancreatitis Onset [NCIt concept]
- Zygosity [NCIt concept]
- cDNA Library Construction [NCIt concept]
- dbGaP Accession Number [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients